Insomnia Market Trends, Research Insights, Share Value, Regional Outlook, Size Estimation and Dynamics by 2027

 

Insomnia Market Overview

Insomnia is commonly recognized and understood as a common sleep disorder common amongst people of different age groups. Also, difficulty in sleeping is often categorized as a person having insomnia. This can exist in an independent state and also, can be conjugated with other kinds of psychiatric issues. It is a lesser-known fact that insomnia is more common with females and the condition is likely to increase during life phases like pregnancy and postpartum, along with the menopause cycle. However, the exact cause of insomnia is still an unknown mystery that is yet to be discovered. There have been many types of research that show that there is an important role of the biological, psychological, alongside behavioral aspects that result at the beginning of insomnia in various individuals. There are both pharmacological, along with the non-pharmacological treatment available in the insomnia market for helping patients that suffer from insomnia. 

Owing to the rate at which insomnia is being diagnosed and the demand for treatments of different kinds, the insomnia market is expected to attain a 4.5% CAGR growth during the ongoing forecast period ending in 2021. 

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/545

Segment Overview

Based on the demand for the treatment for insomnia, the insomnia market has been segmented to cater to the demands of people having different stages and symptoms of insomnia. The market segments are as follows: 

By therapy

Based on the therapy for patients suffering from insomnia, both pharmacological and non-pharmacological therapy is available. Pharmacological therapy is further divided into prescription sleep aids, alongside, over-the-counter sleep aids. Further, non-pharmacological therapy includes hypnotherapy, medical devices, and cognitive behavioral therapy.

By region

Based on the regions, the insomnia market is providing its services in global regions like North America, the Middle East, and Africa, alongside Asian Pacific countries and Europe.

By drug formulation

Medicinal drugs for patients suffering from insomnia are available in the form of capsules and tablets amongst others. These can be taken on the prescription as recommended by the doctor.

Disease condition

The patients suffering from insomnia have disease conditions like poor sleep quality, maintenance of sleep, and having qualitative sleep amongst others. 

Regional Analysis

As mentioned, the global insomnia industry is functional in four major geographies of the world. The North American region is expected to have the highest growth in the global insomnia market. The reason behind this splendid growth resulting in domination for the insomnia market is the timely introduction of new technologies for the potential customers in the market. A similar trend has been adopted by the European countries which are promising a good return for their efforts in the future. However, the APAC region, along with the Middle East and African regions have the lowest market for Insomnia patients and a lot of investment and efforts are required for the insomnia market growth here by the end of the forecast period in 2021.                                                         

Competitive Landscape

The report discusses the scope of the global insomnia market by analyzing the recent developments of the key market players in several locations across the globe. Also, to draw the competitive market landscape, it is important to know the key market players. These are as follows:

  • Vanda Pharmaceuticals Inc. (US)
  • Neurim (Switzerland)
  • Eisai, Co. (Japan)
  • Purdue Pharma L.P. (US)
  • Merck & Co Inc (US)
  • Pfizer, Inc. (US)
  • Astellas (UK)
  • Flynn Pharma (UK)
  • Takeda Pharmaceutical Company (Japan)
  • SkyePharma (UK)
  • Meda Consumer Healthcare Inc (US)
  • Sanofi (France)
  • Biocodex S A (France)
  • Pernix Therapeutics (US)
  • Consumer Healthcare Inc. (Canada)
  • Purdue Pharma L.P. (US)
  • Dainippon Sumitomo (Japan)
  • ECR Pharmaceuticals (US)
  • Johnson & Johnson (US) 

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/insomnia-market-545

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

 

Comments

Post a Comment

Popular posts from this blog

Asthma Inhaler Device market poised to achieve significant growth in the years to come

  Asthma Inhaler Device Market Overview The global asthma inhaler devices market is likely to expand at 5.2 % CAGR during the forecast period (2017-2022) owing to the increasing prevalence of asthma among the crowd, asserts Market Research Future (MRFR). An inflammatory disease of the lungs, asthma is characterized by the difficulty faced while breathing. The symptoms of asthma are often triggered with exposure to allergens such as ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke. Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes airways sensitive to irritations. Drivers and Constraints Impacting the Market With the increasing prevalence of asthma especially among the children, the market is likely to propel over the assessment period. For instance, around 9 million children under five years of age die every year due to the presence of lung diseases. The increasing disposable income and rising preference for combinati...
Read more

Surgical Drapes and Gowns Market Trends with worldwide Industry Analysis, Features, Top Player and Forecast 2030

Image
  Surgical Drapes and Gowns Market Overview The Global Surgical Drapes and Gowns anticipated to have held a market value of USD 2.23 billion in the year 2017 and is expected to grow at a CAGR of 4.4% during the forecast period. Surgical drapes and surgical gowns are used during surgery to maintain sterile surgical field and reduce the risk of contamination and prevention of surgical site infection. Surgical drapes and surgical gowns are used by patients and healthcare professional such as, nurses and doctors. Hospitals, clinics and ambulatory surgical centers are the major end user of the surgical drapes and surgical gowns products. Similarly, According to Public Health England, during 2016 to 2017 around 139,691 procedures were performed in NHS based hospitals in England and about 1,635 surgical site infections (SSIs) detected during the same period. Increasing number of surgeries in healthcare settings and high incidences of hospital-acquired infections are expec...
Read more

Blood Grouping Reagents Market is Expected to Grow at a CAGR of 7.74% by 2027

  Blood Grouping Reagents Market Overview The global blood grouping reagents market is expected to register a CAGR of   7.74%  during the forecast period and is expected to hit USD 2,642.17 million by 2027. Blood grouping reagents are solutions that can be used to determine ABO, Rhesus, Kell and MNS blood groups These classifications of human blood are all based on the presence or absence of certain antigens on the surface of red blood cells. The growth of the global blood grouping reagents market is expected to be driven by increasing prevalence of chronic disorders, increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725 Segment Analysis The global blood grouping reagents market is mainly segmented into product, technique, and test type, end user. On the basis of product, the blood groupin...
Read more